Friska Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-06-2024
- Paid Up Capital ₹ 0.10 M
as on 24-06-2024
- Company Age 9 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 5.00 M
as on 24-06-2024
- Revenue 36.41%
(FY 2023)
- Profit 133.16%
(FY 2023)
- Ebitda 139.60%
(FY 2023)
- Net Worth 20.69%
(FY 2023)
- Total Assets 19.28%
(FY 2023)
About Friska Nutraceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹5.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Hari Sharma, Kulwinder Kaur, Gobind Rajpoot, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232HR2015PTC087102
- Company No.
035570
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jun 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Yamunanagar, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Friska Nutraceuticals Private Limited offer?
Friska Nutraceuticals Private Limited offers a wide range of products and services, including Diabetic Herbal Medicine, Diabetes Powder, Whey Protein, Protein Powder, ON Protein Powder, Nutraceuticals, Allopathic Immunity Booster, Chocolate Protein Powder, Health Food & Drinks, Healthy Snacks.
Who are the key members and board of directors at Friska Nutraceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hari Sharma  | Director | 03-Aug-2020 | Current |
| Kulwinder Kaur | Director | 09-Jun-2015 | Current |
| Gobind Rajpoot | Director | 03-Aug-2020 | Current |
| Tanu Kalia | Director | 09-Jun-2015 | Current |
Financial Performance and Corporate Structure Insights of Friska Nutraceuticals.
Friska Nutraceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 36.41% increase. The company also saw a substantial improvement in profitability, with a 133.16% increase in profit. The company's net worth Soared by an impressive increase of 20.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Friska Nutraceuticals?
In 2023, Friska Nutraceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
5 years 9 months Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Jan 2016 | ₹5.00 M | Satisfied |
How Many Employees Work at Friska Nutraceuticals?
Friska Nutraceuticals has a workforce of 30 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Friska Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Friska Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
